In the published article, there was an error in Figure 1D as published. The labels of feature plots in Figure 1D were misleadingly described. The original labels for “osteoblastic OS cells” should switch with “CAFs”, as well as “Osteoclasts” should switch with “Plasmocytes”. The corrected Figure 1D and its caption appear below.
Figure 1
In the published article, there was an error in Figure 1E as published. The label of “Patient 1” in Figure 1E was incorrectly described, which should be changed to “Patient 3”. The corrected Figure 1E and its caption appear below.
In the published article, there was an error in Supplementary Figure 1A as published. The labels of “Patient 1” in Supplementary Figure 1A were incorrectly described. The six “Patient 1” in inferCNV of Supplementary Figure 1A should need to be corrected in order.
The authors apologize for this error and state that this does not change the scientific conclusions of the article in any way. The original article has been updated.
Publisher’s note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Summary
Keywords
single-cell RNA sequencing, tumor microenvironment, naive osteosarcoma, heterogeneity, osteolysis
Citation
Liu Y, Feng W, Dai Y, Bao M, Yuan Z, He M, Qin Z, Liao S, He J, Huang Q, Yu Z, Zeng Y, Guo B, Huang R, Yang R, Jiang Y, Liao J, Xiao Z, Zhan X, Lin C, Xu J, Ye Y, Ma J, Wei Q and Mo Z (2022) Corrigendum: Single-cell transcriptomics reveals the complexity of the tumor microenvironment of treatment-naive osteosarcoma. Front. Oncol. 12:1077067. doi: 10.3389/fonc.2022.1077067
Received
22 October 2022
Accepted
24 October 2022
Published
15 November 2022
Approved by
Frontiers Editorial Office, Frontiers Media SA, Switzerland
Volume
12 - 2022
Updates
Copyright
© 2022 Liu, Feng, Dai, Bao, Yuan, He, Qin, Liao, He, Huang, Yu, Zeng, Guo, Huang, Yang, Jiang, Liao, Xiao, Zhan, Lin, Xu, Ye, Ma, Wei and Mo.
This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Qingjun Wei, weiqingjun@gxmu.edu.cn; Jie Ma, majie086@163.com; Yu Ye, gxmukjc@126.com; Jiake Xu, jiake.xu@uwa.edu.au
†These authors have contributed equally to this work
This article was submitted to Cancer Genetics, a section of the journal Frontiers in Oncology
Disclaimer
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.